FRANCISCAN HEALTH INDIANAPOLIS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.9M
- Transactions
- 480
- Companies
- 40
- Average per transaction
- $6,076
Who reported the payments
| Novartis | $619,573 |
| Amgen | $358,746 |
| Merck | $251,994 |
| Pfizer | $188,792 |
| Otsuka Pharmaceutical Co., Ltd. | $184,331 |
| Johnson & Johnson | $166,992 |
| Medtronic | $144,698 |
| CSL Behring | $114,851 |
| Incyte Corporation | $107,703 |
| Atricure, Inc. | $94,546 |
| Zimmer Biomet | $75,051 |
| AbbVie | $61,229 |
| Takeda Pharmaceuticals U.S.A., Inc. | $52,721 |
| Tesaro, Inc. | $48,749 |
| Artivion, Inc. | $38,485 |
| Regeneron | $37,277 |
| Mirati Therapeutics, Inc. | $35,178 |
| Jazz Pharmaceuticals Inc. | $32,551 |
| Janssen Research & Development, LLC | $30,229 |
| Eli Lilly | $27,796 |
| Novocure Inc. | $27,674 |
| Esperion Therapeutics, Inc. | $25,508 |
| Boston Scientific | $23,935 |
| American Regent | $22,306 |
| Bristol Myers Squibb | $21,250 |
| Cleerly, Inc. | $19,012 |
| E.r. Squibb & Sons, L.L.C. | $17,290 |
| GSK | $15,348 |
| Daiichi Sankyo Inc. | $11,372 |
| AstraZeneca | $9,835 |
| Genentech, Inc. | $8,762 |
| Lemaitre Vascular, Inc. | $7,497 |
| Astellas Pharma Europe BV | $6,688 |
| Stryker | $5,967 |
| Actelion Pharmaceuticals, Ltd | $5,725 |
| Bioventus LLC | $5,447 |
| EKOS Corporation | $3,500 |
| KARL Storz Endoscopy-america | $2,057 |
| Bayer | $2,000 |
| Edwards Lifesciences | $1,065 |